[1] |
Sun J, Wu S, Jin Z, et al. Lymph node micrometastasis in non-small cell lung cancer[J]. Biomed Pharmacother, 2022, 149: 112817. DOI: 10.1016/j.biopha.2022.112817.
|
[2] |
Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023[J]. CA Cancer J Clin, 2023, 73(1): 17-48. DOI: 10.3322/caac.21763.
|
[3] |
Hua J, Li L, Liu L, et al. The diagnostic value of metabolic, morphological and heterogeneous parameters of 18F-FDG PET/CT in mediastinal lymph node metastasis of non-small cell lung cancer[J]. Nucl Med Commun, 2021, 42(11): 1247-1253. DOI: 10.1097/MNM.0000000000001456.
|
[4] |
Moon Y, Choi SY, Park JK, et al. Risk factors for occult lymph node metastasis in peripheral non-small cell lung cancer with invasive component size 3 cm or less[J]. World J Surg, 2020, 44(5): 1658-1665. DOI: 10.1007/s00268-019-05365-5.
|
[5] |
Seol HY, Kim YS, Kim SJ. Predictive value of 18F-fluorodeoxyglucose positron emission tomography or positron emission tomography/computed tomography for assessment of occult lymph node metastasis in non-small cell lung cancer[J]. Oncology, 2021, 99(2): 96-104. DOI: 10.1159/000509988.
|
[6] |
Zhong Y, She Y, Deng J, et al. Deep learning for prediction of N2 metastasis and survival for clinical stage Ⅰ non-small cell lung cancer[J]. Radiology, 2022, 302(1): 200-211. DOI: 10.1148/radiol.2021210902.
|
[7] |
Xie Y, Zhao H, Guo Y, et al. A PET/CT nomogram incorporating SUVmax and CT radiomics for preoperative nodal staging in non-small cell lung cancer[J]. Eur Radiol, 2021, 31(8): 6030-6038. DOI: 10.1007/s00330-020-07624-9.
pmid: 33560457
|
[8] |
Vansteenkiste J, De Ruysscher D, Eberhardt WE, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2013, 24 Suppl 6: vi89-vi98. DOI: 10.1093/annonc/mdt241.
|
[9] |
Nicholson AG, Chansky K, Crowley J, et al. The international association for the study of lung cancer lung cancer staging project: proposals for the revision of the clinical and pathologic staging of small cell lung cancer in the forthcoming eighth edition of the TNM classification for lung cancer[J]. J Thorac Oncol, 2016, 11(3): 300-311. DOI: 10.1016/j.jtho.2015.10.008.
pmid: 26723244
|
[10] |
Postmus PE, Kerr KM, Oudkerk M, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2017, 28(suppl_4): iv1-iv21. DOI: 10.1093/annonc/mdx222.
|
[11] |
Fang C, Xiang Y, Han W. Preoperative risk factors of lymph node metastasis in clinical N0 lung adenocarcinoma of 3 cm or less in diameter[J]. BMC Surg, 2022, 22(1): 153. DOI: 10.1186/s12893-022-01605-z.
|
[12] |
Zheng Y, Ju S, Huang R, et al. Lymph node metastasis risk factors in clinical stage ⅠA3 lung adenocarcinoma[J]. J Cancer Res Ther, 2023, 19(1): 34-38. DOI: 10.4103/jcrt.jcrt_1370_22.
|
[13] |
王清北, 朱林, 吴正国. NSCLC肺内叶段淋巴结转移规律及全胸腔镜肺叶切除术中淋巴结清扫方式的选择[J]. 国际肿瘤学杂志, 2024, 51(9): 569-577. DOI: 10.3760/cma.j.cn371439-20240422-00095.
|
[14] |
Zhai X, Guo Y, Qian X. Combination of fluorine-18 fluorodeoxyglucose positron-emission tomography/computed tomography (18F-FDG PET/CT) and tumor markers to diagnose lymph node metastasis in non-small cell lung cancer (NSCLC): a retrospective and prospective study[J]. Med Sci Monit, 2020, 26: e922675. DOI: 10.12659/MSM.922675.
|
[15] |
Lederlin M, Puderbach M, Muley T, et al. Correlation of radio- and histomorphological pattern of pulmonary adenocarcinoma[J]. Eur Respir J, 2013, 41(4): 943-951. DOI: 10.1183/09031936.00056612.
pmid: 22835610
|
[16] |
Cong M, Yao H, Liu H, et al. Development and evaluation of a venous computed tomography radiomics model to predict lymph node metastasis from non-small cell lung cancer[J]. Medicine (Baltimore), 2020, 99(18): e20074. DOI: 10.1097/MD.0000000000020074.
|
[17] |
Xu ZQ, Xie LJ, Fan W, et al. Risk factors for mediastinal lymph node metastasis in non-small-cell lung cancer by PET/CT[J]. Nucl Med Commun, 2014, 35(5): 466-471. DOI: 10.1097/MNM.0000000000000077.
|
[18] |
Nakanishi K, Nakamura S, Sugiyama T, et al. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer[J]. BMC Cancer, 2021, 21(1): 983. DOI: 10.1186/s12885-021-08688-6.
pmid: 34474680
|
[19] |
Huang Y, Jiang X, Xu H, et al. Preoperative prediction of mediastinal lymph node metastasis in non-small cell lung cancer based on 18F-FDG PET/CT radiomics[J]. Clin Radiol, 2023, 78(1): 8-17. DOI: 10.1016/j.crad.2022.08.140.
|
[20] |
周见远. 18F-FDG PET/CT影像组学在非小细胞肺癌的临床研究[D]. 武汉: 华中科技大学, 2021. DOI: 10.27157/d.cnki.ghzku.2021.000423.
|